Alastin Targets Crepey Upper Eyelids With Updated Eye Complex

A 12-week clinical study of Alastin's updated Restorative Eye Complex with TriHex+ ($128) found a 22 percent reduction in upper-eyelid fine lines — a result notable because upper lids are rarely evaluated on their own in eye-cream research.

The study enrolled 29 adults, ages 35 to 70, all with moderate to severe signs of aging around the eyes. By the end of the 12 weeks, investigator assessments also found a 34 percent improvement in under-eye puffiness and a 30 percent improvement in crow's feet. The study was small, but the upper-lid data stands out in a category where most research focuses on crow's feet and the under-eye area, where changes are easier to photograph and measure.

Why Upper Eyelids Need Special Attention

Upper-eyelid skin is among the thinnest on the face, and it works constantly. Blinking, squinting and everyday facial movement keep the skin folding and stretching. Over time, it loses firmness and becomes crepey. Upper-lid concerns can range from fine wrinkling to excess skin, which forces researchers to be precise about what they measure.

"That combination means a formula needs to be both cosmetically elegant and appropriate for this highly sensitive area, while addressing visible concerns such as crepiness and loss of smoothness without migrating into the eye," says Alan Widgerow, MD, chief scientific officer at Galderma, Alastin's parent company.

What's Different About the Formula?

Alastin has been rolling out TriHex+ across its lineup, including Skin Nectar ($265) and Restorative Skin Complex ($258). The updated eye cream pairs the brand's original TriHex Technology — developed to support collagen and elastin — with Octapeptide-45, a peptide the company says helps skin produce its own hyaluronic acid. The formula also contains ingredients aimed at improving the appearance of firmness around the eyes.

Can a Cream Compete With Surgery?

The product arrives as consumer interest in eyelid surgery climbs. Eyelid surgeries increased nearly 19 percent in 2025, making blepharoplasty the most popular facial surgery of the year, according to the American Society of Plastic Surgeons. Younger patients are driving some of that demand.

"I recently saw a 33-year-old requesting blepharoplasty," says Brian Biesman, MD, a Nashville, TN oculofacial plastic surgeon. "This is not uncommon today, whereas it was almost unheard of 10-plus years ago."

Dr. Biesman, who evaluated the Alastin formula, draws a clear line between skin quality and anatomy. "Topical products, like Alastin, can help to improve skin quality and can reduce the look of fine wrinkles and visible discoloration," he says. "Surgery manages excess skin, drooping of the eyelid (ptosis) and bulging fat pads."

What This Means for Shoppers

The distinction matters at the counter. Someone noticing the first signs of crepiness may benefit from a targeted topical; someone with significant hooding or excess skin will likely need a procedural approach. Dr. Biesman also sees a role for skin care on both sides of surgery.

"It's not always a one-or-another decision," he says. "Products like Alastin can act as a complement to procedural treatments."

For Alastin, the upper-lid data gives the brand a differentiated claim in a crowded eye-care segment — and gives retailers a concrete number to anchor the $128 price point.